pocketful logo
undefined logo

NSE: undefined BSE: undefined

-

(-%)

Mon, 23 Mar 2026, 06:21 pm

Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    13.50

  • Net Profit

    0.42

  • P/B

    0.44

  • Sector P/E

    72.05

  • P/E

    10.65

  • EV/EBITDA

    4.95

  • Debt/Equity (Industry)

    0.18

  • Interest Cover (Industry)

    12.11

  • ROCE (Industry)

    17.65

  • RONW (Industry)

    14.80

  • ROE

    3.08

  • ROCE

    2.74

  • Debt/Equity

    0.39

  • EPS (TTM)

    0.34

  • Dividend Yield

    0

  • Book Value

    16.49

  • Interest Cover

    4.11

Analysis

all

thumbs up icon

Pros

  • Dr Lalchandani Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Dr Lalchandani Labs is profitable, therefore cash runway is not a concern.
  • Dr Lalchandani Labs is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 3.9x debt.
  • Dr Lalchandani Labs's cash and other short term assets cover its long term commitments.
thumbs up icon

Cons

  • Unable to evaluate Dr Lalchandani Labs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Dr Lalchandani Labs's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Operating cash flow is negative therefore debt is not well covered.
  • High level of physical assets or inventory.
  • The average tenure for the Dr Lalchandani Labs board of directors is less than 3 years, this suggests a new board.

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersMAR 2026SEPT 2025MAR 2025SEPT 2024MAR 2024
Promoters32.9031.1548.3257.1860.78
FII00000
DII00000
Public67.1068.8551.6842.8239.22
Government00000

Read More

Technical Analysis

RSI

45.33

MACD

0.07

50 DMA

16.15

200 DMA

13.37

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic20.8018.6917.2916.5815.1814.4712.36
Fibonacci18.6917.8917.3916.5815.7815.2814.47
Camarilla16.4616.2716.0716.5815.6915.4915.30

Pivots Level: Classic

R3

+4.22

20.80

R2

+2.11

18.69

R1

+0.70

17.29

16.58
16.58
Pivot Point
LTP: 14.81

S1

-1.41

15.18

S2

-2.11

14.47

S3

-4.22

12.36

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    15.76

  • 20-EMA

    15.74

  • 30-EMA

    15.68

  • 50-EMA

    15.41

  • 100-EMA

    14.64

  • 200-EMA

    14.49

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
20 Jan 2026rights1:1 Rights Issue of Equity Shares27 Jan 2026
27 Dec 2025rightsRight Issue of Equity Shares27 Jan 2026
14 Nov 2025board-meetingsHalf Yearly Results
05 Sept 2025agm
18 Sept 2024agm
11 Sept 2023agm
21 Sept 2022agm
06 Sept 2021agm

Read More

Peer Comparison

No Result Found

Dr Lalchandani Labs Ltd logo

Dr Lalchandani Labs Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Read More

About

Dr Lalchandani Labs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations

Industry

Healthcare

Founded

2017

Headquarters

CEO

Arjan Lal Chandani

Employees

Contact

Website icon

Website

Email icon

Email

info@lalchandanipathlab.com

Phone icon

Phone

91-11-49057058

Location icon

Location

M-20 Basement, Greater Kailash-1, New Delhi, New Delhi, 110048

Read More

Company History

YearHistory
2011
  • The partnership firm, Dr A Lalchandani Pathology Laboratories, was originally incorporated at New Delhi.
2013
  • The Companies Act was enacted.
2017
  • The company was incorporated in the name and style of Dr Lalchandani Labs Limited.
  • The company entered into an agreement to take over the existing partnership firm, Dr A Lalchandani Pathology Laboratories, on a going concern basis.
2018
  • The company entered into an agreement to purchase office premises at J-23, Block-J, Lajpat Nagar-III, New Delhi from promoter Mr. Arjan Lal Chandani.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
SINGHI DINESH KUMAR(HUF)Sell2800015.0902 Mar 2026
REETHA VIKRAMBuy4000015.0902 Mar 2026
SUHITH PUNDALIKA BANGERABuy6400016.6202 Mar 2026
SUHITH PUNDALIKA BANGERABuy7600017.1402 Feb 2026
SINGHI DINESH KUMAR(HUF)Sell2800016.7102 Feb 2026
VIVEKRAJUSell2400021.4423 Jan 2026
BHOOMIKA VIKRAM RAOBuy2800022.222 Jan 2026
RAJARAMCHOUDHARYBuy4000016.2611 Dec 2025
VIKRAM KUMARBuy5600018.211 Dec 2025
RAJARAMCHOUDHARYSell2800017.7911 Dec 2025

Read More

News

Bandhan AMC declares dividend with March 10, 2026 record date

Bandhan AMC Limited announces dividend declaration for Large & Mid Cap Fund with record date March 10, 2026. Regular plan offers ₹2.692 per unit, Direct plan ₹3.554 per unit dividend.

06 Mar 2026

mutualfunds

Anuraag Gambhir Acquires 15.05% Stake in Dr. Lalchandani

Anuraag Gambhir acquired 13,00,000 equity shares through rights issue allotment, increasing his stake to 15.05% in Dr. Lalchandani Labs Limited as disclosed under SEBI regulations.

05 Mar 2026

co actions results

Dr Lalchandani Labs Completes Rights Issue Allotment

Dr Lalchandani Labs successfully allotted 43.04 lakh equity shares through rights issue, doubling paid-up share capital to ₹8.64 crore from ₹4.33 crore.

02 Mar 2026

co actions results

Dr Lalchandani Labs Extends Rights Issue Closing Date

Dr Lalchandani Labs Limited has extended its rights issue closing date from February 20, 2026 to February 27, 2026, with on-market trading in rights entitlements also extended to February 24, 2026.

16 Feb 2026

co actions results

Dr Lalchandani Labs Completes Rights Issue Dispatch

Dr Lalchandani Labs Limited has completed dispatch of rights issue material for its ₹433.20 lakhs offering, with issue opening February 4, 2026 and closing February 20, 2026.

31 Jan 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800